You are currently viewing a new version of our website. To view the old version click .
Scientia Pharmaceutica
  • Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
  • Article
  • Open Access

29 June 2007

The Antimycobacterial Derivatives against Potential Pathogenic Strains: 2-Hydroxy-3-(4-phenylpiperazin-1-yl)-propylphenylcarbamates

,
,
,
and
1
Department of Inorganic and Organic Chemistry, Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Heyrovského 1203, CZ-500 05 Hradec Králové, Czech Republic
2
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojárov 10, SK 832 32 Bratislava. Slovak Republic
3
Reference Laboratory for Mycobacterium knasasii, Regional Institute of Public Health in Ostrava, Partyzánské nám. 7, CZ 702 00 Ostrava, Czech Republic
*
Author to whom correspondence should be addressed.

Abstract

According to our previous study 29 derivatives of 2-hydroxy-3-(4-phenylpiperazin-1-yl)-propylphenylcarbamates were tested for in vitro antimycobacterial activity against potential pathogenic strains Mycobacterium kansasii and Mycobacterium avium. The variations in group of compounds were by the substitution on phenyl rings. The Free-Wilson method was used to evaluate structure-antimycobacterial activity relationships. The advantage of compounds under study is in the activity against M. kansasii.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.